• DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG GETS FDA APPROVAL - 7 27 24

  • Jul 27 2024
  • Length: 10 mins
  • Podcast

DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG GETS FDA APPROVAL - 7 27 24 By cover art

DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG GETS FDA APPROVAL - 7 27 24

Listen for free

View show details

  • Summary

  • THERE HAVE BEEN SEVERAL EXCITING RECENT DEVELOPMENTS REGARDING FDA APPROVAL OF DRUGS USED TO TREAT EARLY ALZHEIMER’S DISEASE. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE AND DIRECTOR OF THE STONY BROOK ALZHEIMER’S DISEASE CLINICAL TRIALS PROGRAM.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Hygiene & Healthy Living
Show more Show less

What listeners say about DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG GETS FDA APPROVAL - 7 27 24

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available